Sponsor:
Luventix, Inc.
Code:
NCT06710067
Conditions
Colorectal Cancer
Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Crohn Disease
Celiac Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Colorectal Cancer
Small Intestinal Bacterial Overgrowth Syndrome (SIBO)
Crohn Disease
Celiac Disease
Study ID
NCT06710067
Start date
Oct 1, 2024
Status verified date
Nov, 2024
Completion date
Sep, 2026
Anticipated
Primary completion date
Sep, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
1250 participants
Anticipated
Arms
Disease Cohort
Primary outcome measure
Central contacts
Locations
Unio Health Partners (Gastroenterology)
Recruiting
Encinitas, California, United States, 92024
Contacts
Digestive Health Associates
Recruiting
Santa Monica, California, United States, 90404
Contacts
Westside Gastro Care
Recruiting
Santa Monica, California, United States, 90404
Contacts
Bass Medical Group (Gastroenterology)
Recruiting
Walnut Creek, California, United States, 94598
Contacts
Sponsor
Luventix, Inc.
Last update posted
Dec 13, 2024
Last verified
Nov, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Luventix, Inc. on 2024-12-13.